- Q3 2026 revenues reached a record $1.2B (+10% YoY), driven by Xywav growth (+12% YoY).
- Raised full-year 2026 revenue guidance.
- Incurred $754M in IPR&D due to the Actio acquisition.
Bullish AI Sentiment (+6.5 / 10)
Signal #104568 · SEC 8-K
$JAZZ SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $JAZZ filing catalyst
Why did $JAZZ trigger an AI stock catalyst alert?
$JAZZ triggered a Stock Catalyst AI alert on 2026-11-02 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: Jazz Pharma Reports Record Q3 Revenue of $1.2B (+10% YoY), Raises FY26 Guidance. Key points: - Q3 2026 revenues reached a record $1.2B (+10% YoY), driven by Xywav growth (+12% YoY). - Raised full-year 2026 revenue guidance. - Incurred $754M in IPR&D due to the Actio acquisition.
How did $JAZZ stock react after the SEC filing?
After the SEC 8-K for $JAZZ, observed market reaction: T0 price $214.44. Past moves do not guarantee future results.
Where can I get real-time $JAZZ SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $JAZZ via Telegram and the VIP Web Terminal from €10/month.